share_log

EF Hutton Reiterates Buy on IN8bio, Maintains $8 Price Target

Benzinga ·  Jun 5, 2023 04:10

EF Hutton analyst Tony Butler reiterates IN8bio (NASDAQ:INAB) with a Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment